tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Talis Biomedical reports Q3 revenue $0.1M vs $0.8M last year

Cash and cash equivalents as of September 30, 2023, were $88.0 million.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on TLIS:

Disclaimer & DisclosureReport an Issue

1